Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada

 

Premise A
Premise B
Premise C
Fig. 1: Predicted survival curves for the long-term effects of simvastatin (solid line) compared with usual care (broken line) based on results from the Scandinavian Simvastatin Survival Study (4S study).[20,21] Survival curves for the simvastatin group were plotted according to 3 assumptions for the efficacy of the drug over the 10 years beyond the termination of the 4S study. Premise A = one-time clinical effect, premise B = semi-continuous clinical effect, premise C = continuous clinical effect (see Methods for details).

[Return to text]


| CMAJ April 1, 1997 (vol 156, no 7) / JAMC le 1er avril 1997 (vol 156, no 7) |
/ >